Research Article

Free Triiodothyronine Is Associated with Poor Outcomes after Acute Ischemic Stroke

Table 1

Baseline characteristics (demographic, clinical, and laboratory data) according to the functional status at 3 months.

VariableGood outcome (n = 236)Poor outcome (n = 244) value

Age (years)64.53 ± 14.2270.11 ± 12.02<0.001
Women (n, %)69 (29.2)107 (43.8)0.001
BMI (kg/m2)23.5 ± 3.223.1 ± 3.20.213
Smoking (n, %)78 (33.0)76 (31.1)0.655
Alcohol consumption (n, %)64 (27.1)57 (23.3)0.343
History of stroke (n, %)23 (9.7)26 (10.6)0.742
Hypertension (n, %)131 (55.5)144 (59.0)0.437
AF (n, %)50 (21.1)101 (41.4)<0.001
DM (n, %)60 (25.4)64 (26.20.840
CHD/HF (n, %)47 (19.9)81 (33.2)0.001
SBP at admission140.58 ± 25.82142.27 ± 22.760.449
DBP at admission81.86 ± 15.7880.40 ± 14.530.293
Hemoglobin (g/L)139.09 ± 17.87134.14 ± 20.150.005
Platelet (10^9/L)181.20 ± 60.95173.41 ± 66.840.183
White blood cell (10^9/L)7.63 ± 2.758.48 ± 3.160.002
Glu (mmol/L)7.97 ± 3.318.27 ± 3.300.316
Albumin (g/L)42.41 ± 4.1540.70 ± 4.09<0.001
eGFR (ml/min/1.73 m2)85.12 ± 19.2979.69 ± 21.620.004
Uric acid (μmol/L)363.86 ± 106.12349.23 ± 106.930.162
TG (mmol/L)1.35 (0.93–2.05)1.23 (0.88–1.73)0.05
TC (mmol/L)4.40 ± 1.044.26 ± 0.910.055
HDL (mmol/L)1.24 ± 0.351.27 ± 0.370.334
NIHSS score3 (2–7)13 (8–17)<0.001
TOAST classification
 LAA (n, %)65 (27.5)94 (38.5)<0.001
 CE (n, %)51 (21.6)94 (38.5)
 SAO (n, %)93 (39.4)36 (14.8)
 Unclassified (n, %)27 (11.4)20 (8.2)
Recanalized therapy (n, %)60 (25.4)91 (37.2)0.005
TSH (mU/L)1.97 (1.29–3.22)1.29 (0.73–2.51)<0.001
FT3 (pmol/L)4.04 ± 0.683.53 ± 0.70<0.001
FT4 (pmol/L)16.05 ± 2.5516.64 ± 2.690.014

BMI: body mass index; AF: atrial fibrillation; DM: diabetes mellitus; CHD: coronary heart disease; HF: heart failure; eGFR: estimated glomerular filtration rate; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; Glu: glucose; NIHSS: National Institutes of Health Stroke Scale; TOAST: Trial of Org 10172 in Acute Stroke Treatment; LAA: large-artery atherosclerosis; CE: cardioembolism; SAO: small-artery occlusion; TSH: thyroid-stimulating hormone; FT3: free triiodothyronine; FT4: free thyroxine.